Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cindy Babin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Nanobiotechnology|April 6, 2013
Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NPCindy Babin, Nathalie Majeau, Denis Leclerc
Plos One|February 25, 2012
Engineering of papaya mosaic virus (PapMV) nanoparticles through fusion of the HA11 peptide to several putative surface-exposed sitesGervais Rioux, Cindy Babin, Nathalie Majeau, et al.
Plos One|October 8, 2013
A novel M2e based flu vaccine formulation for dogsDenis Leclerc, Marie Rivest, Cindy Babin, et al.
Vaccine|February 14, 2012
Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]Christian Savard, Marie-Ève Laliberté-Gagné, Cindy Babin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Nanobiotechnology|April 6, 2013
Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NPCindy Babin, Nathalie Majeau, Denis Leclerc
Plos One|February 25, 2012
Engineering of papaya mosaic virus (PapMV) nanoparticles through fusion of the HA11 peptide to several putative surface-exposed sitesGervais Rioux, Cindy Babin, Nathalie Majeau, et al.
Plos One|October 8, 2013
A novel M2e based flu vaccine formulation for dogsDenis Leclerc, Marie Rivest, Cindy Babin, et al.
Vaccine|February 14, 2012
Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]Christian Savard, Marie-Ève Laliberté-Gagné, Cindy Babin, et al.
Pageof 1